Abstract:
The article presents the results of our own studies of patients with ankylosing spondylitis (AS) who underwent COVID-19. Based on the conducted studies, methods of secondary prevention have been developed, including early diagnosis, as well as methods for the treatment of AS, taking into account the peculiarities of the course of COVID-19 and its impact on this disease.
Keywords: COVID-19, ankylosing spondylitis, secondary prevention.